Invention Grant
- Patent Title: Inhalable liquid formulations of DNase I
-
Application No.: US14375439Application Date: 2013-01-31
-
Publication No.: US09603906B2Publication Date: 2017-03-28
- Inventor: Yoseph Shaaltiel , Uri Hanania , Tali Kizhner , Yulia Matiuhin , Liat Fux , Avidor Shulman
- Applicant: Protalix Ltd.
- Applicant Address: IL Carmiel
- Assignee: Protalix Ltd.
- Current Assignee: Protalix Ltd.
- Current Assignee Address: IL Carmiel
- International Application: PCT/IL2013/050096 WO 20130131
- International Announcement: WO2013/114373 WO 20130808
- Main IPC: A61K38/46
- IPC: A61K38/46 ; C12N9/22 ; C12N15/82 ; A61K9/00 ; A61K38/47 ; A61K33/06 ; A61K45/06 ; A61K9/14 ; A61K33/14
Abstract:
An inhalable pharmaceutical composition for pulmonary administration comprising human DNase I and a liquid carrier and, more particularly, but not exclusively, to methods, liquid pharmaceutical inhalation devices and systems for the therapeutic use thereof are provided.
Public/Granted literature
- US20150010617A1 INHALABLE LIQUID FORMULATIONS OF DNASE I Public/Granted day:2015-01-08
Information query
IPC分类:
